These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1221137)

  • 1. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias.
    Ueda M; Kimoto S; Matsuda S; Kawakami M; Mroishige E; Matsumura S; Takeda H
    Jpn J Pharmacol; 1975 Oct; 25(5):549-61. PubMed ID: 1221137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic study of antiarrhythmic agents in man].
    Puech P
    Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.
    Elharrar V; Gaum WE; Zipes DP
    Am J Cardiol; 1977 Apr; 39(4):544-9. PubMed ID: 848439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
    Hashimoto K; Komori S; Ishii M; Kamiya J
    J Cardiovasc Pharmacol; 1984; 6(1):12-9. PubMed ID: 6199593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiarrhythmic agents on heart rate variability indices after myocardial infarction: comparative experimental study of aprindine and procainamide.
    Nogami Y; Takase B; Matsui T; Hattori H; Hamabe A; Fujita M; Ohsuzu F; Ishihara M; Maekara T
    Biomed Pharmacother; 2005 Oct; 59 Suppl 1():S169-73. PubMed ID: 16275488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic and antifibrillatory properties of aprindine.
    Kroll DA; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Aug; 194(2):427-34. PubMed ID: 1151768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ouabain-induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents.
    Foster PR; King RM; Nicoll AB; Zipes DP
    Circulation; 1976 Feb; 53(2):315-21. PubMed ID: 1245038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intropic effects of several antiarrhythmic drugs.
    Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
    Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol.
    Castellucci A
    Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
    Lisin N; Carlier J
    Acta Cardiol; 1974; Suppl 18():117-30. PubMed ID: 4547497
    [No Abstract]   [Full Text] [Related]  

  • 15. Competitive inhibition of cardiac sodium channels by aprindine and lidocaine studied using a maximum upstroke velocity of action potential in guinea pig ventricular muscles.
    Kodama I; Toyama J; Yamada K
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1065-71. PubMed ID: 2439681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Takagi K
    Jpn J Pharmacol; 1974 Aug; 24(4):589-9. PubMed ID: 4455968
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues.
    Carmeliet E; Verdonck F
    Acta Cardiol; 1974; Suppl 18():73-90. PubMed ID: 4547403
    [No Abstract]   [Full Text] [Related]  

  • 18. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
    Fagbemi SO; Chi L; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW; Bonagura JD
    Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.